In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...

KY1005 – now renamed amlitelimab – is one of a handful of new drugs targeting OX40 ligand, an immune system regulator delivered by intravenous infusion once every 28 days. It is also being ...

Roche posted higher sales that beat analysts’ expectations on higher demand for its key drugs.

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active steps to preempt looming U.S. import tariffs. To strengthen its U.S ...

Telangana Anti Narcotics Bureau apprehended Ezeonyili Franklin Uchenna, a Nigerian drug supplier, in Hyderabad after he had ...

The company is strong in oncology, cardiology, immunology, and neurology, with key drugs like Entresto, Cosentyx, Kisqali, and Pluvicto driving growth. Novartis plans to grow by 5% annually ...

Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over year to CHF 15.4 billion and were up 6% at constant exchange rates (CER).

The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA ...

Roche posted higher first-quarter sales that beat analysts' expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...